论文信息 - Three-month ad interim analysis of total anti-SARS-CoV-2 antibodies in healthy recipient of a single BNT162b2 vaccine booster - 字舞流文

Three-month ad interim analysis of total anti-SARS-CoV-2 antibodies in healthy recipient of a single BNT162b2 vaccine booster

G. Lippi | G. Salvagno | S. De Nitto | B. Henry | Gianluca Gianfilippi | L. Pighi | Simone De Nitto

[1] L. Galla,et al. A cohort analysis of SARS-CoV-2 anti-spike protein receptor binding domain (RBD) IgG levels and neutralizing antibodies in fully vaccinated healthcare workers , 2022, Clinical chemistry and laboratory medicine.

[2] J. Dogné,et al. Assessment of the humoral response in Omicron breakthrough cases in healthcare workers who received the BNT162b2 booster , 2022, Clinical chemistry and laboratory medicine.

[3] P. Offit. Covid-19 Boosters — Where from Here? , 2022, The New England journal of medicine.

[4] A. Wald. Booster Vaccination to Reduce SARS-CoV-2 Transmission and Infection. , 2022, JAMA.

[5] G. Lippi,et al. Three-month analysis of total humoral response to Pfizer BNT162b2 mRNA COVID-19 vaccination in healthcare workers , 2021, Journal of Infection.